{"url":"https://whatshealthyandwhy.com/red-clover/menopause-and-hormonal-balance","path":"/red-clover/menopause-and-hormonal-balance","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/red-clover/menopause-and-hormonal-balance.json","markdown":"https://whatshealthyandwhy.com/red-clover/menopause-and-hormonal-balance.md"},"topic":{"slug":"red-clover","name":"Red Clover","url":"https://whatshealthyandwhy.com/red-clover"},"slug":"menopause-and-hormonal-balance","order":1,"title":"Menopause and Hormonal Balance","question":"Does red clover relieve menopause hot flushes?","answer":"Red clover isoflavones likely reduce hot flushes modestly, by about 1.7 per day on average, though results vary widely between trials.","description":"How red clover's plant-based isoflavones ease hot flushes, support bone density, and improve cardiovascular markers during menopause","confidence":3,"confidenceNote":"A meta-analysis of eight RCTs found 1.73 fewer flushes daily with high heterogeneity (87%); two trials of 60 and 72 women agree.","evidenceSummary":{"rctCount":3,"observationalCount":0,"metaAnalysisCount":2,"totalParticipants":"1,000+","replicated":true,"newestStudyYear":2021},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Herbs & Spices","subcategorySlug":"herbs","url":"https://whatshealthyandwhy.com/explore/good-for-you/herbs"},"actions":["Choose products standardized to total isoflavone content; formulations higher in biochanin A did best [1].","Take 40–80 mg of isoflavones daily; the clearest benefit came at 80 mg for 12 weeks or more [1].","Allow 8–12 weeks before judging; shorter trials often show weaker results."],"cautions":["Avoid it, or ask your oncologist first, with hormone-sensitive cancers (breast, ovarian, uterine) or a strong family history; it is a phytoestrogen.","It may interact with blood thinners and tamoxifen; consult your doctor before use."],"simpleText":"Red clover (Trifolium pratense) is a flowering legume that contains some of the richest known plant sources of isoflavones — compounds that mimic estrogen's effects in the body, though far more gently. For women navigating the hormonal shifts of perimenopause and menopause, this makes it one of the better-studied herbal options available. Clinical trials have shown meaningful reductions in hot flush frequency and severity, along with improvements in mood, sleep, and vaginal health [1][2]. A 2021 meta-analysis of eight randomized controlled trials found that red clover reduced hot flushes by an average of 1.73 fewer episodes per day compared to placebo [1]. It also has a reasonable safety record and does not appear to carry the risks associated with hormone replacement therapy.","mediumText":"How Red Clover Works\n\nRed clover contains four main isoflavones: formononetin, biochanin A, daidzein, and genistein. Of these, formononetin and biochanin A are the dominant forms in the plant itself. After ingestion, intestinal bacteria and liver enzymes convert them into the more bioactive forms daidzein and genistein — the same compounds found in soy, but present in a different ratio and alongside unique precursors.\n\nThese isoflavones bind preferentially to estrogen receptor beta (ERβ), which is expressed in the brain, bones, blood vessels, and vaginal tissue. This selectivity is important: unlike estrogen itself, which activates both ERα and ERβ receptors (ERα being the receptor associated with breast and uterine tissue), isoflavones show a much weaker effect on ERα. This is thought to explain why they can provide some estrogenic benefits — reduced flushing, better mood, improved bone turnover — without significantly stimulating breast or uterine tissue [6].\n\nDuring menopause, estrogen levels drop sharply. Hot flushes result from the hypothalamus becoming hypersensitive to small temperature changes when it loses estrogen's stabilizing influence. Isoflavones appear to partially compensate for this deficit at the hypothalamic level, damping the thermoregulatory overreaction that causes flushing. They may also reduce the neurological signaling (involving norepinephrine and serotonin) that triggers the flush itself.\n\nMenopausal Symptom Relief\n\nThe most consistent evidence is for hot flush reduction. Studies using doses of 40–80 mg of standardized red clover isoflavones daily show the clearest effects, with the 2021 meta-analysis finding particular benefit when:\n- Women experienced five or more hot flushes per day at baseline\n- Treatment continued for at least 12 weeks\n- The isoflavone dose reached 80 mg/day\n- Formulations were higher in biochanin A [1]\n\nA 12-week, placebo-controlled trial using 80 mg of dried red clover daily found that the total Menopause Rating Scale score dropped from 20.4 to 10.1 in the red clover group, compared to a much smaller change (20.8 to 17.2) in the placebo group [2]. Improvements were seen across hot flushes, sleep disturbance, mood, and vaginal dryness.\n\nBone and Cardiovascular Health\n\nEstrogen plays a central role in bone maintenance. As it drops during menopause, bone turnover accelerates and mineral density can fall. Red clover isoflavones interact with estrogen receptors on osteoblasts (bone-building cells) and osteoclasts (bone-resorbing cells), helping shift the balance in favor of preservation. While the bone evidence is less robust than for hot flushes, preliminary human data and animal studies suggest a protective role, particularly with higher doses and longer durations of use.\n\nFor cardiovascular health, a landmark 1999 trial found that women taking red clover isoflavones had significantly improved systemic arterial compliance — meaning their arteries became more flexible and less stiff — compared to placebo [5]. This is a meaningful finding: arterial stiffness is an independent predictor of cardiovascular events. Total cholesterol also showed modest reductions. A 2020 meta-analysis of ten studies confirmed that red clover isoflavones can reduce total cholesterol in peri- and postmenopausal women, though effects on HDL, LDL, and triglycerides were less consistent [4].\n\nPractical Use\n\nStandard dosing used in clinical trials:\n- 40–80 mg of standardized red clover isoflavones daily, in one or two doses\n- Most commercial supplements standardize to total isoflavone content (Promensil is the best-studied brand)\n- Effects typically take 8–12 weeks to be noticeable; trials shorter than this often show weaker results\n\nRed clover is generally well tolerated. The most common side effects — mild gastrointestinal discomfort and, rarely, headache — are similar to placebo in most trials [6]. There is a theoretical concern about estrogenic stimulation in women with hormone-sensitive cancers (breast, ovarian, uterine), and most guidelines suggest women with these conditions or a strong family history should avoid phytoestrogens or discuss use with their oncologist. There is no established evidence that red clover isoflavones increase breast cancer risk in otherwise healthy women, but the precaution is standard.\n\nRed clover may interact with blood-thinning medications (it has mild anticoagulant activity) and with tamoxifen. Women on these medications should consult their physician before use.\n\nSee our vitex page for an herb with complementary mechanisms that operates earlier in the hormonal cascade, and our seed cycling page for a food-based approach to hormonal balance.","deepText":"Evidence Review\n\n2021 Meta-Analysis: Hot Flush Reduction (Kanadys et al.)\n\nThe most comprehensive summary of red clover's effects on menopausal symptoms is a 2021 systematic review and meta-analysis published in Nutrients [1]. Researchers analyzed eight randomized controlled trials involving ten separate treatment comparisons across peri- and postmenopausal women. The pooled result showed a statistically significant reduction in daily hot flush frequency for women receiving red clover extract compared to placebo: weighted mean difference of −1.73 hot flushes per day (95% CI: −3.28 to −0.18; p = 0.029).\n\nImportantly, the analysis identified subgroup-dependent effects. The greatest reductions occurred in women who:\n- Experienced at least five hot flushes daily at baseline\n- Received isoflavone doses of 80 mg/day or higher\n- Were treated for 12 weeks or longer\n- Used formulations with a higher proportion of biochanin A\n\nThe authors rated the evidence as clinically meaningful for this specific symptomatic population, while noting that heterogeneity between trials (87%) limits precision of the pooled estimate. The diversity of formulations, extract ratios, and patient populations is the primary source of variability across the red clover literature.\n\n12-Week Randomized Controlled Trial (Shakeri et al., 2015)\n\nShakeri and colleagues enrolled 72 postmenopausal women and randomized them to either two capsules of dried red clover leaves (40 mg total isoflavones) daily or matched placebo for 12 weeks [2]. The primary outcome was the Menopause Rating Scale (MRS) total score, which captures eleven domains including hot flushes, sweating, sleep problems, depressive mood, irritability, anxiety, sexual problems, bladder symptoms, vaginal dryness, joint complaints, and fatigue.\n\nAt baseline, both groups had similar MRS scores (intervention: 20.41, control: 20.77). After 12 weeks:\n- Intervention group MRS: 10.08 (a 51% reduction)\n- Control group MRS: 17.20 (a 17% reduction)\n\nThe between-group difference was statistically significant (p < 0.001). All subscales improved in the red clover group, with the largest gains in vasomotor symptoms (hot flushes and night sweats), sleep, and mood. No serious adverse events were reported.\n\nDouble-Blind RCT: Lipids, Vaginal Health, and Symptoms (Hidalgo et al., 2005)\n\nHidalgo and colleagues conducted a 90-day, double-blind, placebo-controlled trial in 60 postmenopausal women with a Kupperman Index score of ≥15 (indicating moderate to severe symptoms) [3]. Women received either 80 mg/day of red clover isoflavones (commercially standardized supplement) or placebo.\n\nThe red clover group showed significant improvements:\n- Kupperman Index score reduced substantially vs. placebo\n- Triglyceride levels decreased significantly\n- Vaginal cytology improved, indicating a positive estrogenic effect on vaginal epithelium\n- LDL-cholesterol trended downward (non-significant)\n\nThe vaginal cytology finding is noteworthy because it provides objective biological evidence of tissue-level estrogenic activity, supporting the proposed mechanism of ERβ activation in mucosal tissues. The triglyceride effect corroborates findings from other lipid studies.\n\nMeta-Analysis: Lipid Profile (Kanadys et al., 2020)\n\nA 2020 systematic review in Maturitas analyzed ten eligible trials (twelve comparisons) with a combined 910 peri- and postmenopausal women, examining red clover's effect on lipid parameters [4]. The primary finding was a statistically significant reduction in total cholesterol in the red clover groups. Effects on HDL cholesterol, LDL cholesterol, and triglycerides were present in individual studies but inconsistent across the pooled analysis.\n\nThe authors noted that the magnitude of cholesterol reduction was modest and that baseline lipid status, concurrent dietary interventions, and trial duration all influenced outcomes. For women with elevated total cholesterol at baseline, the response appeared more pronounced.\n\nArterial Compliance Study (Nestel et al., 1999)\n\nOne of the earliest and most influential red clover trials examined arterial stiffness rather than menopausal symptoms [5]. Nestel and colleagues administered red clover isoflavones to healthy postmenopausal women and measured systemic arterial compliance — the ability of the aorta and large arteries to expand with each heartbeat and store blood. Arterial stiffness is measured by the inverse of compliance (pulse wave velocity) and is an independent predictor of cardiovascular disease risk.\n\nWomen receiving isoflavones showed a significant 23% improvement in arterial compliance compared to placebo, a finding comparable in magnitude to the effect of hormone replacement therapy in similar populations. Plasma lipids were not significantly changed, suggesting the vascular benefit operates through a direct mechanism (likely nitric oxide production or vessel wall elasticity) rather than through cholesterol modification. This vascular finding remains one of the more compelling pieces of evidence for a direct cardioprotective mechanism.\n\nSafety and Regulatory Context\n\nThe NCCIH classifies red clover as generally well tolerated for short-to-medium term use [6]. In a review of available clinical trial data, serious adverse events attributable to red clover were not reported in any adequately powered study. The main concerns — potential interaction with anticoagulants and theoretical estrogenic stimulation in hormone-sensitive conditions — are precautionary rather than based on documented harm. Several European regulatory bodies (including Germany's Commission E successor organization) recognize red clover preparations as acceptable for menopausal symptom management.\n\nStrength of Evidence Summary …","deepTruncated":true,"references":[{"id":"1","title":"Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","authors":"Kanadys W, Barańska A, Błaszczuk A, Polz-Dacewicz M, Drop B, Kanecki K, Malm M","year":2021,"journal":"Nutrients","pmid":"33920485","url":"https://pubmed.ncbi.nlm.nih.gov/33920485/"},{"id":"2","title":"Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial","authors":"Shakeri F, Taavoni S, Goushegir A, Haghani H","year":2015,"journal":"Climacteric","pmid":"25581426","url":"https://pubmed.ncbi.nlm.nih.gov/25581426/"},{"id":"3","title":"The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study","authors":"Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G","year":2005,"journal":"Gynecological Endocrinology","pmid":"16373244","url":"https://pubmed.ncbi.nlm.nih.gov/16373244/"},{"id":"4","title":"Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women—A systematic review and meta-analysis","authors":"Kanadys W, Baranska A, Jedrych M, Religioni U, Janiszewska M","year":2020,"journal":"Maturitas","pmid":"31883666","url":"https://pubmed.ncbi.nlm.nih.gov/31883666/"},{"id":"5","title":"Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women","authors":"Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, West L","year":1999,"journal":"Journal of Clinical Endocrinology and Metabolism","pmid":"10084567","url":"https://pubmed.ncbi.nlm.nih.gov/10084567/"},{"id":"6","title":"Red Clover: Usefulness and Safety","authors":"National Center for Complementary and Integrative Health","year":2020,"journal":"NCCIH Health Information","url":"https://www.nccih.nih.gov/health/red-clover"}],"wordCount":1660,"source":{"path":"src/content/topics/red-clover/menopause-and-hormonal-balance.md"},"citeAs":"“Does red clover relieve menopause hot flushes?.” What's Healthy and Why. https://whatshealthyandwhy.com/red-clover/menopause-and-hormonal-balance","notice":"General information backed by peer-reviewed research, not medical advice."}